MedPath

Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents

Not Applicable
Completed
Conditions
Obesity
Insulin Resistance
Interventions
Behavioral: Caloric restrictive diet
Registration Number
NCT01901978
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to investigate the changes in subcutaneous adipocyte size, number and gene expression after weight loss and to assess whether those changes contribute to decreases in ectopic fat accumulation and insulin resistance in women between ages of 16-32.

Detailed Description

There are no studies in young women that have prospectively studied changes in fat cell size, gene expression and insulin sensitivity during the transition from overweight/obese to normal weight. Our preliminary data suggest that the presence of ectopic fat accumulation and insulin resistance in obese children could be considered an "early phase" in the development of T2DM. We hypothesize that a 10% weight loss will restore/improve insulin sensitivity. Furthermore, we speculate that the decrease in subcutaneous fat mass after weight loss is due to a decrease in mean adipocyte cell size, but not cell number.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
14
Inclusion Criteria
  • Women ages 16-32
Read More
Exclusion Criteria
  • They will not be on any medications that are known to alter glucose or insulin metabolism, such as oral steroids, or certain psychiatric medications, such as Xeleca, Lithium and Paxil. Patients on diuretics will be excluded.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Weight LossCaloric restrictive dietCaloric restrictive diet
Primary Outcome Measures
NameTimeMethod
Abdominal fat re-distribution with weight loss12 weeks

To assess in young women, the effects of weight loss on abdominal fat distribution.

Secondary Outcome Measures
NameTimeMethod
Adipocyte cell size distrubtion and gene expression12 week

With 10% weight loss, assess changes in cell size distribution and gene expression of adipocytes from the subcutaneous adipose depot.

Trial Locations

Locations (1)

Yale University

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath